ELK1 and breast carcinoma: One study showed that chemokine (C-X-C) ligand 5 (CXCL5) could activate Raf/MEK/ERK, MSK1, Elk-1, and Snail, while E-cadherin was down-regulated in breast cancer cell lines [17].